Capital International Investors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.6M Buy
+661,999
New +$44.1M 0.01% 365
2023
Q3
Sell
-2,340,342
Closed -$301M 437
2023
Q2
$301M Buy
2,340,342
+10,437
+0.4% +$1.26M 0.07% 201
2023
Q1
$271M Buy
2,329,905
+1,172
+0.1% +$131K 0.07% 212
2022
Q4
$264M Buy
2,328,733
+5,577
+0.2% +$612K 0.07% 216
2022
Q3
$187M Sell
2,323,156
-53,724
-2% -$4.55M 0.05% 244
2022
Q2
$177M Buy
2,376,880
+72,128
+3% +$6.58M 0.05% 253
2022
Q1
$295M Buy
2,304,752
+559,844
+32% +$61.2M 0.07% 229
2021
Q4
$234M Buy
1,744,908
+345,920
+25% +$49.7M 0.05% 255
2021
Q3
$191M Buy
1,398,988
+212
+0% +$26.7K 0.04% 251
2021
Q2
$149M Sell
1,398,776
-1,209,232
-46% -$116M 0.03% 268
2021
Q1
$234M Buy
2,608,008
+440
+0% +$41.3K 0.06% 224
2020
Q4
$241M Buy
2,607,568
+1,906,100
+272% +$170M 0.07% 219
2020
Q3
$72.3M Buy
701,468
+37,200
+6% +$3.89M 0.02% 292
2020
Q2
$67.3M Buy
664,268
+74,000
+13% +$6.62M 0.02% 285
2020
Q1
$39.7M Buy
+590,268
New +$36.7M 0.02% 281
2019
Q2
Sell
-4,138,000
Closed -$123M 393
2019
Q1
$123M Sell
4,138,000
-1,530,000
-27% -$53.8M 0.05% 215
2018
Q4
$170M Sell
5,668,000
-7,641,600
-57% -$242M 0.08% 176
2018
Q3
$476M Buy
+13,309,600
New +$413M 0.22% 120

Other funds holding DXCM

Capital International Investors's DXCM Position: Q2 2026 in Review

Capital International Investors opened a new position in DexCom (DXCM) in Q2 2026: 661,999 shares worth $44.6M. The stake represents 0.01% of the portfolio and ranks #365 among its holdings. This is a return to the name: Capital International Investors previously reported a position in DXCM as recently as Q2 2023.

Capital International Investors first reported a position in DXCM in Q3 2018 and has held it in 18 quarters since. The position peaked at $476M in Q3 2018. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Capital International Investors held 661,999 shares of DexCom worth $44.6M as of Q2 2026.
  • DexCom was a new Capital International Investors position in Q2 2026.
  • DexCom made up 0.01% of Capital International Investors's portfolio in Q2 2026, its #365 holding.
  • Capital International Investors first reported a position in DexCom in Q3 2018 and has held it in 18 quarters since.
  • Capital International Investors's DexCom position peaked at $476M in Q3 2018.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.